Aging is associated with attenuation of protective immune responses in both humans and mice. The effects of aging on the immune system are widespread and extend from hematopoietic stem cells (HSCs) and lymphoid precursors. Studies in our laboratory and many others have led to the idea that a major cause of “immunological aging” results from the failure of aged HSCs to give rise to a fully functional B-cell compartment.
We hypothesize that reduced B-cell production in the bone marrow (BM) results in the selective accumulation of long-lived, antigen experienced cell in the periphery. We believe that eventually these cells dominate the peripheral repertoire and the immune system is forced to rely upon them to mount a response to newly encountered pathogens, such as West Nile Virus, SARS, influenza, etc. In order to address the cause of decreased B-cell production in the bone marrow, we have developed unique and innovative tools to approach our hypothesis. These include a transgenic system in mice that allows quantification of aging, as well as the generation of conditionally and reversibly transformed long-term repopulating hematopoietic stem cell (LT-HSC) lines from young and aged mice. These cell lines appear to retain the defects identified in their precursors, i.e. the aged HSC line is unable to reconstitute the B cell compartment.
· Is the defect in B lymphopoiesis in immunologically aged mice a cell intrinsic defect, and/or do microenvironmental changes play a role?
· Can we define the molecular basis for the functional differences between HSCs from young and aged mice using conditionally immortalized stem cell lines?